These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3878813)
1. [Propranolol prevention of hemorrhagic recurrence caused by rupture of esophageal varices: worsened prognosis in ascites and jaundice]. Ink O; Servent L; Attali P; Pelletier G; Buffet C; Etienne JP Gastroenterol Clin Biol; 1985 Nov; 9(11):819-23. PubMed ID: 3878813 [TBL] [Abstract][Full Text] [Related]
2. Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: a multicenter, randomized clinical trial. The Italian Multicenter Project for Propranolol in Prevention of Bleeding. Hepatology; 1988; 8(1):1-5. PubMed ID: 2892771 [TBL] [Abstract][Full Text] [Related]
3. [Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients]. Poynard T; Aubert A; Naveau S; Lemman M; Chaput JC Gastroenterol Clin Biol; 1988 Dec; 12(12):899-905. PubMed ID: 3069544 [TBL] [Abstract][Full Text] [Related]
4. [How many cirrhotic patients may receive propranolol after digestive hemorrhage?]. Silvain C; Chauvin C; Verneau A; Carretier M; Beauchant M Gastroenterol Clin Biol; 1985 Oct; 9(10):670-3. PubMed ID: 3877654 [TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. Poynard T; Calès P; Pasta L; Ideo G; Pascal JP; Pagliaro L; Lebrec D N Engl J Med; 1991 May; 324(22):1532-8. PubMed ID: 1674104 [TBL] [Abstract][Full Text] [Related]
6. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. Burroughs AK; Jenkins WJ; Sherlock S; Dunk A; Walt RP; Osuafor TO; Mackie S; Dick R N Engl J Med; 1983 Dec; 309(25):1539-42. PubMed ID: 6361553 [TBL] [Abstract][Full Text] [Related]
7. Propranolol alone may not be acceptable to prevent first esophageal variceal bleeding in Japanese cirrhotic patients: randomized controlled trial. Tomikawa M; Shimabukuro R; Okita K; Tsutsumi N; Akahoshi T; Hashizume M; Sugimachi K J Gastroenterol Hepatol; 2004 May; 19(5):576-81. PubMed ID: 15086603 [TBL] [Abstract][Full Text] [Related]
8. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Zaman A; Hapke R; Flora K; Rosen HR; Benner K Am J Gastroenterol; 1999 Nov; 94(11):3292-6. PubMed ID: 10566732 [TBL] [Abstract][Full Text] [Related]
9. [Prevention of digestive hemorrhage recurrence in hepatic cirrhosis with propranolol. A 4 years' follow-up study]. Jirón MI; Soto JR; Wolff C; Armas R Rev Med Chil; 1993 Feb; 121(2):133-8. PubMed ID: 8303108 [TBL] [Abstract][Full Text] [Related]
10. [Endoscopic ligation of esophageal varices: prevention of hemorrhagic recurrences caused by rupture of esophageal varices. Results in 45 patients]. Bizollon T; Gaudin JL; Jacob P; Bouvet B; Evreux M; Souquet JC; Trépo C Gastroenterol Clin Biol; 1995 Nov; 19(11):909-13. PubMed ID: 8746050 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices. Park DK; Um SH; Lee JW; Lee JB; Kim YS; Park CH; Jin YT; Chun HJ; Lee HS; Lee SW; Choi JH; Kim CD; Ryu HS; Hyun JH J Gastroenterol Hepatol; 2004 Sep; 19(9):1042-51. PubMed ID: 15304123 [TBL] [Abstract][Full Text] [Related]
12. The efficacy of endoscopic ligation for the prevention of variceal rebleeding in cirrhotic patients according to the hepatocellular function. Lopes CV; Pereira-Lima JC; Pereira-Lima LF; Hornos AP; Marques DL; Cassal AP; Marroni CA Hepatogastroenterology; 2004; 51(55):195-200. PubMed ID: 15011863 [TBL] [Abstract][Full Text] [Related]
13. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Sarin SK; Wadhawan M; Agarwal SR; Tyagi P; Sharma BC Am J Gastroenterol; 2005 Apr; 100(4):797-804. PubMed ID: 15784021 [TBL] [Abstract][Full Text] [Related]
14. [Controlled study of propranolol in the prevention of recurrent hemorrhage in cirrhotic patients]. Queuniet AM; Czernichow P; Lerebours E; Ducrotte P; Tranvouez JL; Colin R Gastroenterol Clin Biol; 1987 Jan; 11(1):41-7. PubMed ID: 3549413 [TBL] [Abstract][Full Text] [Related]
15. Prevention of variceal rebleeding by propranolol: should it work? Does it work? Erlinger S; Lebrec D Hepatology; 1987; 7(6):1388-9. PubMed ID: 3500104 [No Abstract] [Full Text] [Related]
16. Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Evrard S; Dumonceau JM; Delhaye M; Golstein P; Devière J; Le Moine O Endoscopy; 2003 Sep; 35(9):729-35. PubMed ID: 12929019 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors associated with rebleeding in cirrhotic inpatients complicated with esophageal variceal bleeding. Wang MT; Liu T; Ma XQ; He J Chin Med J (Engl); 2011 May; 124(10):1493-7. PubMed ID: 21740804 [TBL] [Abstract][Full Text] [Related]
18. Esophageal variceal ligation for acute variceal bleeding: results of three years' follow-up. Altintaş E; Sezgin O; Kaçar S; Tunç B; Parlak E; Altiparmak E; Saritaş U Turk J Gastroenterol; 2004 Mar; 15(1):27-33. PubMed ID: 15264118 [TBL] [Abstract][Full Text] [Related]
19. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature. Zoller WG; Gross M Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240 [TBL] [Abstract][Full Text] [Related]
20. Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis. Lay CS; Tsai YT; Lee FY; Lai YL; Yu CJ; Chen CB; Peng CY J Gastroenterol Hepatol; 2006 Feb; 21(2):413-9. PubMed ID: 16509867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]